Global (United States, European Union and China) Parkinson's Disease (PD) Drugs Market Research Report 2019-2025

Global (United States, European Union and China) Parkinson's Disease (PD) Drugs Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Dopamine Agonist
1.3.3 Monoamine Oxidase Inhibitors
1.3.4 Acetylcholinesterase Inhibitors
1.3.5 Glutamate Inhibitors
1.4 Market Segment by Application
1.4.1 Global Parkinson's Disease (PD) Drugs Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Family
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease (PD) Drugs Market Size
2.1.1 Global Parkinson's Disease (PD) Drugs Revenue 2014-2025
2.1.2 Global Parkinson's Disease (PD) Drugs Sales 2014-2025
2.2 Parkinson's Disease (PD) Drugs Growth Rate by Regions
2.2.1 Global Parkinson's Disease (PD) Drugs Sales by Regions 2014-2019
2.2.2 Global Parkinson's Disease (PD) Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Parkinson's Disease (PD) Drugs Sales by Manufacturers
3.1.1 Parkinson's Disease (PD) Drugs Sales by Manufacturers 2014-2019
3.1.2 Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Parkinson's Disease (PD) Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Parkinson's Disease (PD) Drugs Price by Manufacturers
3.4 Key Manufacturers Parkinson's Disease (PD) Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
3.6 Key Manufacturers Parkinson's Disease (PD) Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Dopamine Agonist Sales and Revenue (2014-2019)
4.1.2 Monoamine Oxidase Inhibitors Sales and Revenue (2014-2019)
4.1.3 Acetylcholinesterase Inhibitors Sales and Revenue (2014-2019)
4.1.4 Glutamate Inhibitors Sales and Revenue (2014-2019)
4.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type
4.3 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type
4.4 Parkinson's Disease (PD) Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Parkinson's Disease (PD) Drugs Sales by Application
6 United States
6.1 United States Parkinson's Disease (PD) Drugs Breakdown Data by Company
6.2 United States Parkinson's Disease (PD) Drugs Breakdown Data by Type
6.3 United States Parkinson's Disease (PD) Drugs Breakdown Data by Application
7 European Union
7.1 European Union Parkinson's Disease (PD) Drugs Breakdown Data by Company
7.2 European Union Parkinson's Disease (PD) Drugs Breakdown Data by Type
7.3 European Union Parkinson's Disease (PD) Drugs Breakdown Data by Application
8 China
8.1 China Parkinson's Disease (PD) Drugs Breakdown Data by Company
8.2 China Parkinson's Disease (PD) Drugs Breakdown Data by Type
8.3 China Parkinson's Disease (PD) Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Parkinson's Disease (PD) Drugs Breakdown Data by Company
9.2 Rest of World Parkinson's Disease (PD) Drugs Breakdown Data by Type
9.3 Rest of World Parkinson's Disease (PD) Drugs Breakdown Data by Application
9.4 Rest of World Parkinson's Disease (PD) Drugs Breakdown Data by Countries
9.4.1 Rest of World Parkinson's Disease (PD) Drugs Sales by Countries
9.4.2 Rest of World Parkinson's Disease (PD) Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.1.4 Parkinson's Disease (PD) Drugs Product Introduction
10.1.5 Boehringer Ingelheim Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.2.4 Parkinson's Disease (PD) Drugs Product Introduction
10.2.5 GlaxoSmithKline Recent Development
10.3 Novartis
10.3.1 Novartis Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.3.4 Parkinson's Disease (PD) Drugs Product Introduction
10.3.5 Novartis Recent Development
10.4 Teva Pharmaceutical Industries
10.4.1 Teva Pharmaceutical Industries Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.4.4 Parkinson's Disease (PD) Drugs Product Introduction
10.4.5 Teva Pharmaceutical Industries Recent Development
10.5 AbbVie
10.5.1 AbbVie Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.5.4 Parkinson's Disease (PD) Drugs Product Introduction
10.5.5 AbbVie Recent Development
10.6 Abital Pharma
10.6.1 Abital Pharma Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.6.4 Parkinson's Disease (PD) Drugs Product Introduction
10.6.5 Abital Pharma Recent Development
10.7 Addex Therapeutics
10.7.1 Addex Therapeutics Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.7.4 Parkinson's Disease (PD) Drugs Product Introduction
10.7.5 Addex Therapeutics Recent Development
10.8 Biogen
10.8.1 Biogen Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.8.4 Parkinson's Disease (PD) Drugs Product Introduction
10.8.5 Biogen Recent Development
10.9 Eisai
10.9.1 Eisai Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.9.4 Parkinson's Disease (PD) Drugs Product Introduction
10.9.5 Eisai Recent Development
10.10 Eli Lilly
10.10.1 Eli Lilly Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Parkinson's Disease (PD) Drugs
10.10.4 Parkinson's Disease (PD) Drugs Product Introduction
10.10.5 Eli Lilly Recent Development
10.11 F. Hoffmann-La Roche
10.12 H. Lundbeck
10.13 Impax Laboratories
10.14 Kyowa Hakko Kirin
10.15 Otsuka Pharmaceutical
10.16 Pfizer
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Parkinson's Disease (PD) Drugs Sales Channels
11.2.2 Parkinson's Disease (PD) Drugs Distributors
11.3 Parkinson's Disease (PD) Drugs Customers
12 Market Forecast
12.1 Global Parkinson's Disease (PD) Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Parkinson's Disease (PD) Drugs Sales Forecast by Type
12.3 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application
12.4 Parkinson's Disease (PD) Drugs Forecast by Regions
12.4.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Parkinson's Disease (PD) Drugs Product Picture
Table Parkinson's Disease (PD) Drugs Key Market Segments
Table Major Manufacturers Parkinson's Disease (PD) Drugs Covered in This Report
Table Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type 2019-2025 (K Pcs) & (Million US$)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Shar by Type 2014-2025
Figure Dopamine Agonist Figures
Table Major Manufacturers of Dopamine Agonist
Figure Monoamine Oxidase Inhibitors Figures
Table Major Manufacturers of Monoamine Oxidase Inhibitors
Figure Acetylcholinesterase Inhibitors Figures
Table Major Manufacturers of Acetylcholinesterase Inhibitors
Figure Glutamate Inhibitors Figures
Table Major Manufacturers of Glutamate Inhibitors
Table Global Parkinson's Disease (PD) Drugs Market Share by Application 2019-2025 (K Pcs)
Figure Hospital Use Case
Figure Family Use Case
Figure Parkinson's Disease (PD) Drugs Report Years Considered
Figure Global Parkinson's Disease (PD) Drugs Market Size 2014-2025 (Million US$)
Figure Global Parkinson's Disease (PD) Drugs Sales 2014-2019 (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Parkinson's Disease (PD) Drugs Sales by Regions 2014-2019 (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions 2014-2019
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions 2014-2019
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions in 2019
Table Global Parkinson's Disease (PD) Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2019
Table Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2014-2019)
Figure Parkinson's Disease (PD) Drugs Value Share by Manufacturers in 2019
Table Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Parkinson's Disease (PD) Drugs Price (2014-2019) (USD/Pcs)
Table Key Manufacturers Parkinson's Disease (PD) Drugs Plants/Factories Distribution
Table Key Manufacturers Parkinson's Disease (PD) Drugs Area Served
Table Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
Table Key Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Dopamine Agonist Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Monoamine Oxidase Inhibitors Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Acetylcholinesterase Inhibitors Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Glutamate Inhibitors Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Parkinson's Disease (PD) Drugs Sales by Type (2014-2019) (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Type (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2018
Table Global Parkinson's Disease (PD) Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type in 2018
Table Parkinson's Disease (PD) Drugs Price by Type 2014-2019 (USD/Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales by Application (2014-2019) (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Application (2014-2019)
Figure Global Sales Parkinson's Disease (PD) Drugs Market Share by Application (2014-2019)
Figure Global Sales Parkinson's Disease (PD) Drugs Market Share by Application (2014-2019)
Figure United States Parkinson's Disease (PD) Drugs Sales Growth Rate 2014-2019 (K Pcs)
Figure United States Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table United States Parkinson's Disease (PD) Drugs Sales by Company (2014-2019) (K Pcs)
Table United States Parkinson's Disease (PD) Drugs Sales Market Share by Company (2014-2019)
Figure United States Parkinson's Disease (PD) Drugs Sales Market Share by Company in 2019
Table United States Parkinson's Disease (PD) Drugs Sales by Type (2014-2019) (K Pcs)
Table United States Parkinson's Disease (PD) Drugs Sales Market Share by Type (2014-2019)
Figure United States Parkinson's Disease (PD) Drugs Market Share by Type in 2019
Table United States Parkinson's Disease (PD) Drugs Sales by Application (2014-2019) (K Pcs)
Table United States Parkinson's Disease (PD) Drugs Sales Market Share by Application (2014-2019)
Figure United States Parkinson's Disease (PD) Drugs Market Share by Application in 2019
Figure European Union Parkinson's Disease (PD) Drugs Sales Growth Rate 2014-2019 (K Pcs)
Figure European Union Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Parkinson's Disease (PD) Drugs Sales by Company (2014-2019) (K Pcs)
Table European Union Parkinson's Disease (PD) Drugs Sales Market Share by Company (2014-2019)
Figure European Union Parkinson's Disease (PD) Drugs Sales Market Share by Company in 2019
Table European Union Parkinson's Disease (PD) Drugs Sales by Type (2014-2019) (K Pcs)
Table European Union Parkinson's Disease (PD) Drugs Sales Market Share by Type (2014-2019)
Figure 2018 European Union Parkinson's Disease (PD) Drugs Market Share by Type
Table European Union Parkinson's Disease (PD) Drugs Sales by Application (2014-2019) (K Pcs)
Table European Union Parkinson's Disease (PD) Drugs Sales Market Share by Application (2014-2019)
Figure 2018 European Union Parkinson's Disease (PD) Drugs Market Share by Application
Figure China Parkinson's Disease (PD) Drugs Sales Growth Rate 2014-2019 (K Pcs)
Figure China Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table China Parkinson's Disease (PD) Drugs Sales by Company (2014-2019) (K Pcs)
Table China Parkinson's Disease (PD) Drugs Sales Market Share by Company (2014-2019)
Figure China Parkinson's Disease (PD) Drugs Sales Market Share by Company in 2019
Table China Parkinson's Disease (PD) Drugs Sales by Type (2014-2019) (K Pcs)
Table China Parkinson's Disease (PD) Drugs Sales Market Share by Type (2014-2019)
Figure China Parkinson's Disease (PD) Drugs Market Share by Type in 2019
Table China Parkinson's Disease (PD) Drugs Sales by Application (2014-2019) (K Pcs)
Table China Parkinson's Disease (PD) Drugs Sales Market Share by Application (2014-2019)
Figure China Parkinson's Disease (PD) Drugs Market Share by Application in 2019
Figure Rest of World Parkinson's Disease (PD) Drugs Sales Growth Rate 2014-2019 (K Pcs)
Figure Rest of World Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Parkinson's Disease (PD) Drugs Sales by Company (2014-2019) (K Pcs)
Table Rest of World Parkinson's Disease (PD) Drugs Sales Market Share by Company (2014-2019)
Figure Rest of World Parkinson's Disease (PD) Drugs Sales Market Share by Company in 2019
Table Rest of World Parkinson's Disease (PD) Drugs Sales by Type (2014-2019) (K Pcs)
Table Rest of World Parkinson's Disease (PD) Drugs Sales Market Share by Type (2014-2019)
Figure Rest of World Parkinson's Disease (PD) Drugs Market Share by Type in 2019
Table Rest of World Parkinson's Disease (PD) Drugs Sales by Application (2014-2019) (K Pcs)
Table Rest of World Parkinson's Disease (PD) Drugs Sales Market Share by Application (2014-2019)
Figure Rest of World Parkinson's Disease (PD) Drugs Market Share by Application in 2019
Table Rest of World Parkinson's Disease (PD) Drugs Sales by Countries (2014-2019) (K Pcs)
Table Rest of World Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2014-2019)
Figure Rest of World Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2019
Table Rest of World Parkinson's Disease (PD) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2014-2019)
Figure Rest of World Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2019
Figure Japan Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (K Pcs)
Figure Korea Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (K Pcs)
Figure India Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure India Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (K Pcs)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (K Pcs)
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table Novartis Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table Novartis Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Description and Business Overview
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table Teva Pharmaceutical Industries Recent Development
Table AbbVie Company Details
Table AbbVie Description and Business Overview
Table AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table AbbVie Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table AbbVie Recent Development
Table Abital Pharma Company Details
Table Abital Pharma Description and Business Overview
Table Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abital Pharma Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table Abital Pharma Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table Abital Pharma Recent Development
Table Addex Therapeutics Company Details
Table Addex Therapeutics Description and Business Overview
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table Addex Therapeutics Recent Development
Table Biogen Company Details
Table Biogen Description and Business Overview
Table Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table Biogen Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table Biogen Recent Development
Table Eisai Company Details
Table Eisai Description and Business Overview
Table Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table Eisai Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table Eisai Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Description and Business Overview
Table Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019)
Table Eli Lilly Parkinson's Disease (PD) Drugs Sales Market Share in Global Market
Table Eli Lilly Recent Development
Table F. Hoffmann-La Roche Company Details
Table H. Lundbeck Company Details
Table Impax Laboratories Company Details
Table Kyowa Hakko Kirin Company Details
Table Otsuka Pharmaceutical Company Details
Table Pfizer Company Details
Figure Parkinson's Disease (PD) Drugs Value Chain
Table Parkinson's Disease (PD) Drugs Distributors List
Table Parkinson's Disease (PD) Drugs Customers List
Table Global Parkinson's Disease (PD) Drugs Sales Forecast 2019-2025 (K Pcs) & (Million US$)
Figure Global Parkinson's Disease (PD) Drugs Sales Forecast 2019-2025 (K Pcs)
Figure Global Parkinson's Disease (PD) Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Type 2019-2025 (K Pcs)
Figure Global Parkinson's Disease (PD) Drugs Sales Forecast by Type 2019-2025 (K Pcs)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Application 2019-2025 (K Pcs)
Figure Global Parkinson's Disease (PD) Drugs Sales Forecast by Application 2019-2025 (K Pcs)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Regions 2019-2025 (K Pcs)
Figure Global Parkinson's Disease (PD) Drugs Sales Forecast by Regions 2019-2025 (K Pcs)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Parkinson's Disease (PD) Drugs Revenue Forecast by Regions 2019-2025 (K Pcs)
Figure Global Parkinson's Disease (PD) Drugs Revenue Forecast by Regions 2019-2025 (K Pcs)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure United States Parkinson's Disease (PD) Drugs Sales Forecast 2019-2025 (K Pcs)
Figure United States Parkinson's Disease (PD) Drugs Revenue Forecast 2019-2025 (Million US$)
Figure European Union Parkinson's Disease (PD) Drugs Sales Forecast 2019-2025 (K Pcs)
Figure European Union Parkinson's Disease (PD) Drugs Revenue Forecast 2019-2025 (Million US$)
Figure China Parkinson's Disease (PD) Drugs Sales Forecast 2019-2025 (K Pcs)
Figure China Parkinson's Disease (PD) Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Japan Parkinson's Disease (PD) Drugs Sales Forecast 2019-2025 (K Pcs)
Figure Japan Parkinson's Disease (PD) Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Korea Parkinson's Disease (PD) Drugs Sales Forecast 2019-2025 (K Pcs)
Figure Korea Parkinson's Disease (PD) Drugs Revenue Forecast 2019-2025 (Million US$)
Figure India Parkinson's Disease (PD) Drugs Sales Forecast 2019-2025 (K Pcs)
Figure India Parkinson's Disease (PD) Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Sales Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs